Where it comes from

Made in
The same cells as neurotensin, cut from the same precursor
Sent out by
With neurotensin
Acts on
  • Neurotensin receptors

What it does

  • Acts like neurotensin at the same receptors, and is destroyed in seconds in blood 1
  • Shares neurotensin’s last three residues, which is the part the receptors read, and that is why the two cannot easily be told apart by their effects
  • Studied in the brain for its effects on dopamine, pain and body temperature, always alongside neurotensin rather than instead of it 2

In medicine

  • None of its own: no medicine, and no clinical assay measures it
  • The blood test used in cohort studies measures pro-neurotensin, the uncut precursor the two peptides come from, so published “neurotensin” risk associations belong to both

Beyond the body’s own use

  • Not studied as a treatment. It was identified in pig spinal cord in 1984 and has had no programme of its own since 1
  • What is genuinely unknown is whether it does anything the longer peptide does not. Because it is cleared faster and binds more weakly, it may be no more than a second product of the same cut; nobody has made a stable version to find out 2

Sources

  1. Minamino et al., Neuromedin N: a novel neurotensin-like peptide identified in porcine spinal cord, Biochemical and Biophysical Research Communications 1984
  2. Thompson et al., Influence of the neurotensin signalling system on feeding and satiety, Neuropharmacology 2025

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.